These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10953307)

  • 21. A23187 stimulates translocation of 5-lipoxygenase from cytosol to membrane in human alveolar macrophages.
    Pueringer RJ; Bahns CC; Monick MM; Hunninghake GW
    Am J Physiol; 1992 Apr; 262(4 Pt 1):L454-8. PubMed ID: 1314503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Inhibitor of 5-Lipoxygenase (5-LOX) Prevents Oxidative Stress-Induced Cell Death of Retinal Pigment Epithelium (RPE) Cells.
    Subramanian P; Mendez EF; Becerra SP
    Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4581-8. PubMed ID: 27635633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of 5-lipoxygenase on in vitro growth of human mammary carcinoma cell line MCF-7.
    Przylipiak A; Hafner J; Przylipiak J; Köhn FM; Runnebaum B; Rabe T
    Gynecol Obstet Invest; 1998; 46(1):61-4. PubMed ID: 9692346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K-ras mutations in lung cancer: the "mysterious mutation".
    Hirsch FR
    Clin Lung Cancer; 2006 Jul; 8(1):11-2. PubMed ID: 16870039
    [No Abstract]   [Full Text] [Related]  

  • 25. MK-886 enhances tumour necrosis factor-alpha-induced differentiation and apoptosis.
    Stika J; Vondrácek J; Hofmanová J; Simek V; Kozubík A
    Cancer Lett; 2006 Jun; 237(2):263-71. PubMed ID: 16039040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of cellular proliferation and induction of apoptosis in a human lymphoma cell line after treatment with selective lipoxygenase inhibitors.
    Anderson KM; Ondrey FG; Harris JE
    Adv Exp Med Biol; 1999; 469():563-8. PubMed ID: 10667383
    [No Abstract]   [Full Text] [Related]  

  • 27. Five-lipoxygenase inhibitors reduce Panc-1 survival: the mode of cell death and synergism of MK886 with gamma linolenic acid.
    Anderson KM; Seed T; Meng J; Ou D; Alrefai WA; Harris JE
    Anticancer Res; 1998; 18(2A):791-800. PubMed ID: 9615721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor.
    Brideau C; Chan C; Charleson S; Denis D; Evans JF; Ford-Hutchinson AW; Fortin R; Gillard JW; Guay J; Guévremont D
    Can J Physiol Pharmacol; 1992 Jun; 70(6):799-807. PubMed ID: 1330258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the arachidonate and ATP binding sites of human 5-lipoxygenase using photoaffinity labeling and enzyme immobilization.
    Falgueyret JP; Denis D; Macdonald D; Hutchinson JH; Riendeau D
    Biochemistry; 1995 Oct; 34(41):13603-11. PubMed ID: 7577949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactive oxygen species and redox-induced programmed cell death due to MK 886: cells ("soil") "trump" agent ("seed").
    Anderson KM; Rubenstein M; Alrefai WA; Dudeja P; Tsui P; Guinan P; Harris JE
    In Vivo; 2005; 19(1):109-18. PubMed ID: 15796162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity.
    MacCarrone M; Lorenzon T; Guerrieri P; Agrò AF
    Eur J Biochem; 1999 Oct; 265(1):27-34. PubMed ID: 10491155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
    Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
    Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth.
    Moody TW; Leyton J; Martinez A; Hong S; Malkinson A; Mulshine JL
    Exp Lung Res; 1998; 24(4):617-28. PubMed ID: 9659587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible mechanism(s) of action of bortezomib in a patient with bronchioloalveolar carcinoma.
    Garfield DH; Cadranel JL
    Lung Cancer; 2007 Aug; 57(2):249-50. PubMed ID: 17599646
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells.
    Sarveswaran S; Chakraborty D; Chitale D; Sears R; Ghosh J
    J Biol Chem; 2015 Feb; 290(8):4994-5006. PubMed ID: 25540201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Lipoxygenase and human pulmonary artery endothelial cell proliferation.
    Walker JL; Loscalzo J; Zhang YY
    Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H585-93. PubMed ID: 11788406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged remission of disseminated atypical adenomatous hyperplasia under gefitinib.
    Pastorino U; Calabrò E; Tamborini E; Marchianò A; Orsenigo M; Fabbri A; Sozzi G; Novello S; De Marinis F
    J Thorac Oncol; 2009 Feb; 4(2):266-7. PubMed ID: 19179908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induce limited differentiation and apoptosis.
    Anderson KM; Seed T; Plate JM; Jajeh A; Meng J; Harris JE
    Leuk Res; 1995 Nov; 19(11):789-801. PubMed ID: 8551795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective killing of cancer cells and regression of tumor growth by K27 targeting sulfiredoxin.
    Kim J; Lee GR; Kim H; Jo YJ; Hong SE; Lee J; Lee HI; Jang YS; Oh SH; Lee HJ; Lee JS; Jeong W
    Free Radic Biol Med; 2016 Dec; 101():384-392. PubMed ID: 27825965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-lipoxygenase-activating protein inhibitor MK-886 induces apoptosis in gastric cancer through upregulation of p27kip1 and bax.
    Fan XM; Tu SP; Lam SK; Wang WP; Wu J; Wong WM; Yuen MF; Lin MC; Kung HF; Wong BC
    J Gastroenterol Hepatol; 2004 Jan; 19(1):31-7. PubMed ID: 14675240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.